Additionally, M2-like TAMs secrete EGF-like ligands to activate EGFR pathway in lung cancer cells, which ultimately promoting EMT that can be inhibited by a cannabinoid receptor 2 (CB2) agonist JWH-015 via downregulation of EGFR signaling [11]. Here, CNR2 is linked to lung carcinoma.